Baseline and follow-up symptom burden (Panel A: DSI, dominant symptom intensity;
Panel B: GSS, global symptom severity) in the study cohort with reflux
hypersensitivity (RH), segregated by medical vs. surgical management. Symptom
burden significantly improved on follow up (p<0.001). Although baseline
symptom burden metrics were similar among medical and surgical groups, there was
lesser residual symptom burden among surgical patients compared to medical
patients (p=0.09 and p=0.01 for DSI and GSS, respectively).